Clinical trial Recruiting at 1 site Observational

AI-assisted analgesia copilot to guide remifentanil dosing during general anesthesia

Official title: AI-assisted Analgesia Copilot System for Proper Management of Nociception

Run by Pontificia Universidad Catolica de Chile · NCT07253012 · Data updated 2026-11-12

This project will test an AI 'co-pilot' that monitors multiple physiological signals during general anesthesia to guide remifentanil dosing and reduce over- or under-dosing for adults having elective surgeries of 2–4 hours.

More Artificial Intelligence (AI) trials

Quick facts

Study typeObservational
SexAll
Enrollment150 (estimated)
SponsorPontificia Universidad Catolica de Chile
Academic / other
Locations2 sites (Santiago and 1 other locations)
StatusRecruiting
StartedJanuary 29, 2026
Main results expectedOctober 27, 2026
Study endsOctober 27, 2027
Registry record updatedMarch 9, 2026
Trial IDNCT07253012 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for elective surgery under general anesthesia expected to last between two and four hours are the intended participants.

Probably not a fit

Patients undergoing emergency surgery, pregnant patients, those with pre-existing mental or intellectual disability, drug dependence, surgeries shorter than two hours or longer than four hours, or cases with major intraoperative complications are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project develops and applies a machine-learning/AI co-pilot that integrates data from hemodynamic monitors, BIS, TOF, ANI, anesthesia machines, and infusion pumps to monitor nociception in real time. The system aims to distinguish genuine nociceptive responses from confounding physiological signals and to support precise titration of remifentanil using target-controlled infusion. Data will be captured during elective general anesthesia cases lasting between two and four hours to train and validate the algorithm in a clinical operating-room environment. The intent is to create a clinical implementation tool that can provide actionable, real-time guidance for individualized opioid dosing.

Why it matters

Potential benefit: If successful, this could enable more precise remifentanil dosing during surgery, lowering opioid-related complications and improving recovery and cost-effectiveness.

How similar studies have gone: Prior work using nociception indices and PK/PD models has shown promise, but fully integrated AI co-pilot systems for intraoperative opioid titration remain largely unproven in routine clinical practice.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled for elective surgery with general anesthesia.
* Surgeries scheduled to last at least two hours.

Exclusion Criteria:

* Patients undergoing emergency surgery.
* Pregnant women.
* Presence of a mental or intellectual disability before the hospitalization.
* Drug dependence.
* Surgeries scheduled for more than 4 hours.
* Intraoperative complications requiring changes in routine behavior.

Where it's running

  • Hospital Clinico UC Christus
    Santiago, Chile
    Recruiting
  • Division de Anestesiologia
    Santiago, Chile
    Not yet recruiting

Study contacts

  • Principal investigator: Victor Contreras, RN, MSN — Pontificia Universidad Catolica de Chile
  • Study coordinator: Victor Contreras, RN, MSN
  • Email: vecontre@uc.cl
  • Phone: +56955049217

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.